SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Sino Biopharmaceutical to Receive $358 Million in Payments

Sino Biopharmaceutical says SBP Group is to receive $358 million in upfront and near-term payments.

Related stories